Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Manic Episode”

97 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 97 results

Post-approval studies (Phase 4)Study completedNCT00397020
What this trial is testing

Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapine for Adults With Acute Mania or Mixed Episodes

Who this might be right for
Bipolar Disorder
University of California, San Diego 30
Large-scale testing (Phase 3)Study completedNCT00228059
What this trial is testing

An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder.

Who this might be right for
Bipolar I Disorder
Novartis 132
Post-approval studies (Phase 4)Study completedNCT00202293
What this trial is testing

Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features

Who this might be right for
Bipolar DisorderSchizoaffective Disorder
Melbourne Health 83
Testing effectiveness (Phase 2)Study completedNCT01822678
What this trial is testing

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder

Who this might be right for
Bipolar I Disorder
Bial - Portela C S.A. 161
Large-scale testing (Phase 3)Study completedNCT00159796
What this trial is testing

3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)

Who this might be right for
Bipolar Disorder
Organon and Co 489
Not applicableStudy completedNCT00454883
What this trial is testing

Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.

Who this might be right for
Affective Psychosis, BipolarManiaManic-Depressive Psychosis
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 379
Large-scale testing (Phase 3)Study completedNCT01396291
What this trial is testing

Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)

Who this might be right for
Bipolar 1 Disorder
Forest Laboratories 561
Not applicableStudy completedNCT01731171
What this trial is testing

Probiotics to Prevent Relapse After Hospitalization for Mania

Who this might be right for
Bipolar DisorderSchizoaffective Disorder
Sheppard Pratt Health System 66
Not applicableStudy completedNCT00538629
What this trial is testing

Non Interventional Study In Bipolar Disorder And Schizophrenia With Zeldox

Who this might be right for
Bipolar DisorderSchizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 471
Large-scale testing (Phase 3)Study completedNCT00606177
What this trial is testing

A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 99
Large-scale testing (Phase 3)Study completedNCT00253149
What this trial is testing

The Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder

Who this might be right for
Bipolar DisordersManic Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 158
Large-scale testing (Phase 3)Study completedNCT04819776
What this trial is testing

Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Who this might be right for
Bipolar I Disorder
Vanda Pharmaceuticals 417
Not applicableStudy completedNCT00534222
What this trial is testing

Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect

Who this might be right for
ManiaSchizophrenia
AstraZeneca 387
Not applicableStudy completedNCT06426134
What this trial is testing

Ketosis Impact on Signs & Symptoms of Schizophrenia and Bipolar disorderS

Who this might be right for
Schizophrenia and Related DisordersPsychosisBipolar and Related Disorders+2 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 28
Post-approval studies (Phase 4)Study completedNCT00360126
What this trial is testing

An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder

Who this might be right for
Bipolar Disorder
GlaxoSmithKline 11
Large-scale testing (Phase 3)Active Not RecruitingNCT06608641
What this trial is testing

Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients

Who this might be right for
Bipolar 1 Disorder
Jina Pharmaceuticals Inc. 490
Large-scale testing (Phase 3)Looking for participantsNCT06951711
What this trial is testing

Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

Who this might be right for
Bipolar Disorder Type I With Mania or Mania With Mixed Features
Bristol-Myers Squibb 274
Large-scale testing (Phase 3)Looking for participantsNCT06929273
What this trial is testing

Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

Who this might be right for
Bipolar Disorder Type I With Mania
Bristol-Myers Squibb 450
Large-scale testing (Phase 3)Study completedNCT06462586
What this trial is testing

Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania

Who this might be right for
Bipolar Disorder, Manic
Intra-Cellular Therapies, Inc. 354
Large-scale testing (Phase 3)Study completedNCT00606229
What this trial is testing

Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 41
Next Page